Severe Gastrointestinal Graft-versus-Host Disease Following Haploidentical Stem Cell Transplantation Presenting With Passage of a Colonic Cast Authors: Faisal Abubaker, Mariam Adnan, Noora Almannai, Noora Butti, Eman Aljufairi Published: 2026 ABSTRACT AbstractGastrointestinal graft-versus-host disease (GI-GVHD) is a life-threatening complication of allogeneic hematopoietic stem cell transplantation with increased severity in haploidentical settings. We report a fatal case of severe, steroid-refractory GI-GVHD in a 67-year-old male following haploidentical stem cell transplantation for myelodysplastic syndrome with excess blasts-2. The patient developed multiorgan complications including refractory cytopenias, severe infections, pleural effusions, and hepatic dysfunction. A rare and striking manifestation occurred with the passage of a colonic cast, reflecting profound mucosal injury and full-thickness epithelial sloughing. Despite maximal immunosuppressive therapy, including corticosteroids, calcineurin inhibition, ruxolitinib, and extracorporeal photopheresis, the patient deteriorated and ultimately expired. This case highlights an extreme presentation of GI-GVHD with rare colonic cast formation and emphasizes the aggressive nature of steroid-refractory disease.Keywords: Colonic Cast, Gastrointestinal GVHD, Haploidentical Transplant, Mucosal Sloughing, Steroid-Refractory GVHD Introduction Graft-versus-host disease (GVHD) remains a major complication following allogeneic hematopoietic stem cell transplantation, with gastrointestinal (GI) involvement being a major determinant of prognosis. GI-GVHD typically manifests as diarrhea, abdominal pain, and GI bleeding, resulting from donor T-cell–mediated epithelial injury.1,2 The risk and severity are increased in haploidentical transplantation due to greater human leukocyte antigen disparity and heightened alloimmune activation. Severe disease may progress to mucosal denudation, hemorrhage, and multiorgan failure. However, passage of a colonic cast is exceedingly rare, representing near-complete sloughing of colonic mucosa and indicating advanced, fulminant disease. Case Presentation A 67-year-old male with a history of type 2 diabetes mellitus, benign prostatic hyperplasia, and prior perianal fistula diagnosed with myelodysplastic syndrome with excess blasts-2, diagnosed in February 2025. Cytogenetic analysis demonstrated complex abnormalities including monosomy 7, consistent with high-risk disease. He underwent haploidentical stem cell transplantation from his son on January 12, 2026, following reduced-intensity conditioning with a thiotepa, busulfan, fludarabine regimen (thiotepa, busulfan, and fludarabine). The pretransplant course was complicated by extended-spectrum beta-lactamase-producing Escherichia coli and Proteus species septic episodes, perianal abscess formation, recurrent pleural effusions, and progressive cytopenias. Following transplantation, neutrophil engraftment occurred on day +17; however, the patient developed persistent pancytopenia, recurrent infections, worsening pleural effusions with lung collapse, hepatic dysfunction with ascites, and encephalopathy requiring intensive care admission. Hemodynamic instability necessitated intermittent vasopressor support. On day +30 post-transplantation, he developed sudden-onset profuse watery diarrhea exceeding 1.5 L per day, severe abdominal pain, and hypotension. Despite supportive management, his condition rapidly deteriorated, and he passed a tubular colonic-shaped tissue structure consistent with a colonic cast, indicating severe mucosal sloughing due to fulminant GI-GVHD (Figure 1). Passage of colonic cast. Endoscopic findings (Figure 2) showed: •Diffusely edematous and congested rectal mucosa with complete loss of vascular markings, accompanied by multifocal areas of subepithelial hemorrhage. Diffusely edematous and congested rectal mucosa with complete loss of vascular markings, accompanied by multifocal areas of subepithelial hemorrhage. •The mucosa appeared markedly friable with features suggestive of severe proctitis. The mucosa appeared markedly friable with features suggestive of severe proctitis. •Cytomegalovirus immunostaining: Negative. Cytomegalovirus immunostaining: Negative. Diffusely edematous and congested rectal mucosa with complete loss of vascular markings, accompanied by multifocal areas of subepithelial hemorrhage. The mucosa appeared markedly friable with features suggestive of severe proctitis. Histopathology biopsy confirmed the following: •Colonic biopsies show surface erosion, expanded inflamed lamina propria with fibrosis, and patchy crypt dropout (Figure 3). Colonic biopsies show surface erosion, expanded inflamed lamina propria with fibrosis, and patchy crypt dropout (Figure 3). •Examination at higher magnification (Figure 4 and 5) showed numerous apoptotic bodies in the crypts Examination at higher magnification (Figure 4 and 5) showed numerous apoptotic bodies in the crypts Colonic biopsies show surface erosion, expanded inflamed lamina propria with fibrosis, and patchy crypt dropout. Examination at higher magnification showed numerous apoptotic bodies in the crypts. Higher-magnification image showing crypt epithelial apoptosis and crypt injury. Unique Event: Colonic Cast Passage Colonic cast formation is an exceptionally rare manifestation of GI-GVHD and reflects near-complete sloughing of the mucosal and submucosal layers of the colon. This represents catastrophic epithelial destruction and is considered a terminal manifestation of fulminant disease.3 Management The patient was managed with aggressive multidisciplinary immunosuppression, including high-dose intravenous methylprednisolone, followed by calcineurin inhibition with cyclosporine and tacrolimus. Due to steroid-refractory disease, ruxolitinib was initiated,4,5 and extracorporeal photopheresis was administered. Broad-spectrum antimicrobials were administered for recurrent septic episodes, and total parenteral nutrition was initiated due to severe GI dysfunction. Despite maximal therapy, the disease remained refractory. Outcome The patient progressed to refractory multiorgan failure characterized by persistent pancytopenia, recurrent sepsis, severe GI bleeding, refractory shock, and metabolic deterioration. Despite intensive care support, he ultimately succumbed to his illness. Discussion This case highlights a catastrophic manifestation of GI-GVHD following haploidentical stem cell transplantation. Early onset disease, steroid refractoriness, and rapid progression to multiorgan failure reflect the aggressive immunobiology associated with haploidentical transplantation. The development of a colonic cast represents an extreme and rarely reported endpoint of mucosal destruction, indicating near-total epithelial loss due to uncontrolled immune-mediated injury. Histopathological features of crypt apoptosis and dropout remain the diagnostic hallmark of severe GVHD.6 Despite modern immunosuppressive strategies, including Janus kinase inhibition and extracorporeal photopheresis, outcomes in fulminant steroid-refractory disease remain poor. This case underscores the urgent need for improved therapeutic strategies in high-risk transplant populations. Literature Review GI-GVHD occurs in up to 60% to 80% of patients undergoing allogeneic stem cell transplantation and remains a leading cause of transplant-related mortality.7 Pathogenesis involves conditioning-related epithelial injury, activation of antigen-presenting cells, donor T-cell proliferation, cytokine-driven inflammation (including tumor necrosis factor alpha, interleukin-1, and interleukin-1),1,8 and disruption of intestinal barrier integrity. Emerging evidence also highlights the role of gut microbiome dysbiosis in modulating disease severity and steroid responsiveness.9 Clinically, GI-GVHD ranges from mild secretory diarrhea to severe hemorrhagic colitis, ileus, intestinal perforation, sepsis, and multiorgan failure. Grade III–IV disease, particularly when steroid-refractory, is associated with poor outcomes. Approximately 40% to 50% of cases are refractory to corticosteroids.2,7 Management includes high-dose corticosteroids as first-line therapy, followed by calcineurin inhibitors such as tacrolimus or cyclosporine. Additional therapies include ruxolitinib, anti-TNF agents, and extracorporeal photopheresis.10 Despite therapeutic advances, outcomes in fulminant disease remain poor, particularly in haploidentical transplantation. Conclusion Severe GI-GVHD may rarely present with colonic cast formation, reflecting catastrophic mucosal injury. This case underscores the aggressive nature of steroid-refractory GVHD and highlights the importance of early recognition and escalation of therapy, although prognosis in such extreme cases remains poor. Footnotes Conflicts of Interest: The authors disclose no conflicts. Funding: The authors report no funding. Ethical Statement: Ethical approval was not required for this case report in accordance with institutional policies. Written informed consent was obtained from the patient’s legal guardian (his son) for publication of this case report and accompanying images. Reporting Guidelines: This case report was prepared in accordance with the CARE guidelines. References